Aberrant expression of DROSHA at mRNA or protein level was shown to be associated with patient survival and tumor progression in several types of cancer, including pleomorphic adenomas [27], esophageal cancer [28], cervical cancer [29] and ovarian cancer [30]. This evidence concerns the gene DROSHA and ovarian carcinoma.